Rivaxo®
Therapeutic Segment:
Anti-Coagulant
Generic Name:
Rivaroxaban
Indication
Tablet
- 10MG
- 15MG
- 20MG
For the treatment of the following conditions:
- Reduction of Risk of Stroke and Systemic Embolism in Non-valvular Atrial Fibrillation
- Deep Vein Thrombosis
- Pulmonary Embolism
- Reduction in the risk of recurrence of deep vein thrombosis and of pulmonary embolism following initial 6 months’ treatment for DVT and/or PE.
- Prophylaxis of DVT, which may lead to PE in patients undergoing knee or hip replacement surgery.